Complex Regional Pain Syndrome
Intrathecal drug delivery systems may be ineffective in reducing pain and oral opioid intake in individuals with complex regional pain syndrome.
Interdisciplinary pain management programs incorporate physical and occupational therapy, pain psychology, medication management, and biofeedback.
The use of a novel frequency pairing for transcranial magnetic stimulation may effectively relieve upper and lower extremity pain associated with complex regional pain syndrome.
Researchers have developed a weighted score that may be useful in the differential diagnosis of complex regional pain syndrome.
Ketamine infusion may provide short-term pain relief for patients with complex regional pain syndrome.
Patients diagnosed with complex regional pain syndrome (CRPS) demonstrate significant structural and functional brain changes in regions associated with movement and pain.
Dorsal root ganglion stimulation is more likely than spinal cord stimulation to provide pain relief in patients with neuropathic pain conditions affecting the lower extremities.
Patients who learn to manage their pain with CBT and exercise can reduce pain levels.
A combination of ketamine infusion treatment and psychotherapy was found to attenuate PTSD manifestation and reduce pain scores.
The lack of evidence base for treating chronic pain with neurostimulation resulted in the development of guideline recommendations based on systematic review and meta-analysis of published studies.
Average delay from onset to diagnosis is 4 years, study shows.
A review of different approaches for preventing transmission of pain signals to the brain.
Clinical Pain Advisor Articles
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Opioids: Clinician Concern and Prescribing Practices
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Ensuring Safety During Long-Term Opioid Therapy
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain
- Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
- CDC: 8.8% of Individuals in the United States Uninsured in First Half of 2018
- Patient Experiences Shed Light on Diagnostic Errors
- Topical Migraine Trigger Point Treatment as Effective as Injection
- Wikipedia in Medical Education: An Educator's Guide to Crowdsourcing